MS relapses are more common in spring and summer, coinciding with warmer, drier weather and atmospheric changes, a study ...

The CEMIP enzyme inhibits the growth of oligodendrocytes and may serve as a therapeutic target to boost myelin repair in MS, ...

Taking lipoic acid failed to ease progressive MS symptoms in a clinical trial, but the antioxidant showed signs of slowing ...

A clinical trial testing whether music therapy can make botulinum toxin injections for spasticity more comfortable is ...

Myelin loss disrupts the coordination of signals between brain regions, impairing the accurate processing of information, ...

Columnist Ben Hofmeister never feels he's quite ready for the unpredictability of MS, which makes planning for life's challenges hard.

A new analysis found that eating both oily fish and wholemeal/wholegrain bread may help lower one's risk of developing ...

Sanofi will not be pursuing approval of tolebrutinib for PPMS, and an FDA decision on the therapy in nonrelapsing SPMS will ...

As she prepares to change medications for her MS, columnist Leigh Anne Nelson explores the U.S. government’s registry on ...

Treatment with equecabtagene autoleucel, known for short as eque-cel — Iaso Biotherapeutics‘ CAR T-cell therapy candidate for people with… ...

Disease-modifying therapies for MS that prevent brain volume loss are linked to reduced long-term disability, new data show.

The presentation of multiple sclerosis (MS) varies between individuals, and doctors can’t always diagnose the disease after one episode of MS-like symptoms. A single episode of neurological symptoms ...